March 12, 2018 / 7:36 AM / in 3 months

BRIEF-Astrazeneca Says MYSTIC Trial Final Analysis Of Overall Survival Now Expected In H2

March 12 (Reuters) - Astrazeneca Plc:

* ‍PROVIDES UPDATE ON MYSTIC TRIAL TIMELINE​

* ‍FINAL ANALYSIS OF OVERALL SURVIVAL (OS) IS NOW EXPECTED IN SECOND HALF OF 2018 (PREVIOUSLY ANTICIPATED IN FIRST HALF)​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below